Olmetec en es it fr

Olmetec Brand names, Olmetec Analogs

Olmetec Brand Names Mixture

  • No information avaliable

Olmetec Chemical_Formula


Olmetec RX_link


Olmetec fda sheet

Olmetec FDA

Olmetec msds (material safety sheet)

Olmetec MSDS

Olmetec Synthesis Reference

No information avaliable

Olmetec Molecular Weight

558.585 g/mol

Olmetec Melting Point

175-180 oC

Olmetec H2O Solubility

No information avaliable

Olmetec State


Olmetec LogP


Olmetec Dosage Forms


Olmetec Indication

For the treatment of hypertension

Olmetec Pharmacology

Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.

Olmetec Absorption

Bioavailability is about 26%. Food does not affect the bioavailability of olmesartan.

Olmetec side effects and Toxicity

Symptoms of overdose include dehydration (dry mouth, excessive thirst, muscle pain or cramps, nausea and vomiting, weakness), dizziness, low blood pressure, and slow or irregular heartbeat.

Olmetec Patient Information

Olmetec Organisms Affected

Humans and other mammals